pRC319 Citations (1)

Originally described in: Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.
Citorik RJ, Mimee M, Lu TK Nat Biotechnol. 2014 Sep 21. doi: 10.1038/nbt.3011. PubMed Journal

---

Articles Citing pRC319

Articles
Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria. Kiga K, Tan XE, Ibarra-Chavez R, Watanabe S, Aiba Y, Sato'o Y, Li FY, Sasahara T, Cui B, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Azam AH, Suzuki M, Penades JR, Cui L. Nat Commun. 2020 Jun 10;11(1):2934. doi: 10.1038/s41467-020-16731-6. PubMed

If you have published an article using this material, please email us at to have your article added to this page.